Back
Valneva SE 10K Form
Sell
44
INRLF
Valneva SE
Last Price:
4.00
Seasonality Move:
5.22%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive INRLF News And Ratings
See the #1 stock for the next 7 days that we like better than INRLF
INRLF Financial Statistics
Sales & Book Value
| Annual Sales: | $166.41M |
|---|---|
| Cash Flow: | $-76.87M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.02 |
| Price / Book: | 3.93 |
Profitability
| EPS (TTM): | -0.79040 |
|---|---|
| Net Income (TTM): | $-109.81M |
| Gross Margin: | $57.2M |
| Return on Equity: | -56.33% |
| Return on Assets: | -18.56% |
Valneva SE Earnings Forecast
Key Valneva SE Financial Ratios
- The Gross Profit Margin over the past 19 years for INRLF is 34.37%.
- The Selling, General & Administrative Expenses for INRLF have been equal to 62.81% of Gross Profit Margin.
- The Research & Development expenses have been 38.97% of Revenue.
- The Interest Expense is -23.00% of Operating Income.
- The Net Earning history of INRLF is -65.99% of Total Revenues.
- Per Share Earnings over the last 19 years have been positive in 9 years.
Valneva SE Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | INRLF |
| Website: | valneva.com |
Debt
| Debt-to-Equity Ratio: | 1.38 |
|---|---|
| Current Ratio: | 1.65 |
| Quick Ratio: | 1.06 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
INRLF Technical Analysis vs Fundamental Analysis
Sell
44
Valneva SE (INRLF)
is a Sell
Is Valneva SE a Buy or a Sell?
-
Valneva SE stock is rated a Sell
The current Valneva SE [INRLF] share price is $4.00. The Score for INRLF is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.